Skip to main content
. 2021 Sep 29;12:728204. doi: 10.3389/fpsyt.2021.728204

Figure 2.

Figure 2

Direct comparison of adjunctive aripiprazole, metformin and PGD in the treatment of hyperprolactinemia for schizophrenic patients. (A) Direct comparisons of adjunctive aripiprazole, metformin and PGD for reducing prolactin levels with all primary antipsychotics. (B) Direct comparisons of adjunctive aripiprazole, metformin and PGD in PANSS score changes with all primary antipsychotics. (C–E) Direct comparisons of adjunctive aripiprazole, metformin and PGD for reducing prolactin levels when using risperidone, amisulpride and olanzapine respectively as primary antipsychotics, respectively.